Why OpenAI’s big revenue target may be a stretch

Why OpenAI’s big revenue target may be a stretch

One analyst worries OpenAI will have trouble reaching its financial goals — and even staying afloat — if conditions shift in the AI market.

Related Posts

Enanta Pharma CSO Or Yat Sun sells $34k in stock

Enanta Pharma CSO Or Yat Sun sells $34k in stock

Here’s how the best investors protect their money from market bubbles and FOMO

Here’s how the best investors protect their money from ...

Raykov Rosty sells Fennec Pharmaceuticals (FENC) shares for $75,400

Raykov Rosty sells Fennec Pharmaceuticals (FENC) shares...

Enanta Pharma chief product officer sells $30k in stock

Enanta Pharma chief product officer sells $30k in stock

Two of Brazil’s nine central bank seats likely to be unfilled at January meeting, sources say

Two of Brazil’s nine central bank seats likely to be un...

Adaptive Biotechnologies CSO Robins sells $672,515 in ADPT stock

Adaptive Biotechnologies CSO Robins sells $672,515 in A...